期刊文献+

血管内皮细胞生长因子在类风湿关节炎患者血清中的水平及其临床意义 被引量:8

The serum vascular endothelial growth factor level in rheumatoid arthritis patients and its clinical significance
在线阅读 下载PDF
导出
摘要 目的:研究类风湿关节炎(RA)患者血清中血管内皮细胞生长因子(VEGF)的水平及其临床意义。方法:采用酶联免疫吸附试验(ELISA)方法检测RA活动组(73例)、RA缓解组(39例)及健康对照组(52例)的血清VEGF的质量浓度,分析血清VEGF质量浓度与RA病情活动指标之间的关系。结果:RA活动组的血清VEGF质量浓度明显高于健康对照组,差异有统计学意义(P<0.01);RA活动组患者的血清VEGF质量浓度明显高于RA缓解组患者和健康对照组,差异有统计学意义(P<0.01),RA缓解组血清VEGF质量浓度和健康对照组比较差异无统计学意义(P>0.05)。C反应蛋白(CRP)和关节疼痛数与VEGF质量浓度呈明显正相关关系(P<0.01)。结论:血清VEGF质量浓度在RA患者中明显升高,且与病情具有相关性,在临床上可作为RA病情判断和疗效评估的指标之一。 Objective: To investigate the serum vascular endothelial growth factor (VEGF) level in rheumatoid arthritis(RA) patients and its clinical significance. Methods: 112 patients with RA and 52 healthy controls were enrolled in this study. The serum concentration of VEGF was determined by enzyme-linked immunosorbent assay (ELISA). Results: The serum VEGF level in patients with active RA was significantly higher than that in clinical remission RA patients and healthy controls ( P d0.01). There was no statistical difference in VEGF level between clinical remission RA patients and healthy controls ( P 〉0.05). The VEGF concentration was positively associated with the C-reactive protein (CRP) level and arthralgia counts ( P 〈0.01). Conclusion: There was a positive correlation between the serum VEGF concentration and RA condition. The serum VEGF level could be a potential marker for evaluating the severity of RA.
出处 《广西医科大学学报》 CAS 2017年第1期20-23,共4页 Journal of Guangxi Medical University
基金 首都医学发展科研基金资助项目(No.2009-3221)
关键词 类风湿关节炎 血管内皮生长因子 相关性 rheumatoid arthritis vascular endothelial growth factor correlation
  • 相关文献

参考文献4

二级参考文献34

  • 1杨曙梅,王惠民,丛辉,曹利华.抗环瓜氨酸肽抗体的定量检测在类风湿性关节炎诊断中的应用[J].江西医学检验,2005,23(1):7-8. 被引量:10
  • 2邢影,徐忠信,莽靖,钱佳利.大鼠局灶性脑缺血-再灌注损伤血管内皮细胞生长因子表达的研究[J].中国危重病急救医学,2005,17(3):174-176. 被引量:17
  • 3解燕春,李承晏,叶飞,聂德云,王杨.亚低温对局灶性脑缺血大鼠血管新生的影响[J].中华物理医学与康复杂志,2007,29(2):91-93. 被引量:7
  • 4董怡.类风湿关节炎[M]//任高.内科学.第6版.北京:人民卫生出版社,2004:885-89l.
  • 5Schmemfing RL,Delbanco TL.The rheumatoid factor:an anlysis of clinical utdity[J]. Am J Med, 1991,91 (5) : 528.
  • 6Schellekens GA, visser H , De Jong BA,et al.The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrul-linated peptide[J]. Aarthritis Rheumatoid, 2000,43(1 ) : 155.
  • 7Menard HA, Lapionte E, Rochdi M,et a l.Insights into rheumatoid arthritis derived from the Sa immune system[J]. Arthritis Res, 2000, 2(6) : 429.
  • 8Vasishta A. Diagnosing early-onset rheumatoid arthritis : the role of anti-CCP antibodies[J]. Am Clin Lab, 2002, 21 (7) : 34.
  • 9Rojas-Serrano J, Burgos-Vargas R,P6rez LL,et al.Very recent on-set arthritis: the value of initial rheumatologist evaluation and an- ti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis[J]. Clin Rheumatol, 2009,28(10) : 1135.
  • 10Predeteanu D, Varzaru L, Balanescu A, et al.Anti-cyclic citrulli-hated peptide antibodles-activity markers in rhemnatoid arthritis[J]. J Med Life, 2009, 2(1):36.

共引文献1336

同被引文献113

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部